Alexander Roderick MacKenzie
Director/Board Member presso ViiV Healthcare Ltd.
Profilo
Alexander Roderick MacKenzie is currently the Vice Chairman at Transcelerate Biopharma, Inc. He is also the Director at The National Health Council and Director at ViiV Healthcare Ltd.
He previously worked as the Chief Development Officer & Executive VP at Pfizer Inc. and as a Professor-Neurobiology at Duke University.
MacKenzie holds a doctorate degree from Imperial College London and an undergraduate degree from the University of Glasgow.
Posizioni attive di Alexander Roderick MacKenzie
Società | Posizione | Inizio |
---|---|---|
ViiV Healthcare Ltd.
ViiV Healthcare Ltd. Pharmaceuticals: MajorHealth Technology ViiV Healthcare Ltd. manufactures and distributes pharmaceutical products. Its medicine include Triumeq, Tivicay, Selzentry, Celesentri, Epzicom, Kivexa, Ziagen, Trizivir, Combivir, Retrovir AZT, Lexiva, Telzir, Viracept and Rescriptor. The company was founded in 2009 and is headquartered in Brentford, the United Kingdom. | Director/Board Member | 09/06/2010 |
The National Health Council
The National Health Council Miscellaneous Commercial ServicesCommercial Services The National Health Council provides united voice for people with chronic diseases and disabilities and their family caregivers. The company was founded in 1920 and is headquartered in Washington, DC. | Director/Board Member | 10/12/2019 |
Transcelerate Biopharma, Inc.
Transcelerate Biopharma, Inc. BiotechnologyHealth Technology Transcelerate Biopharma, Inc. is a non-profit consortium that collaborates with pharmaceutical and biotechnology companies to improve the delivery of new medicines. The non-profit company is based in King of Prussia, PA. The organization's mission is to identify, prioritize, design, and facilitate implementation of solutions to drive the efficient, effective, and high-quality delivery of new medicines. Transcelerate has 20 member companies and 30+ initiatives focused on improving the patient and site experience, enhancing sponsor efficiencies and drug safety, and harmonizing processes and sharing information. The company was founded by Garry Arthur Neil, and Janice Chang has been the CEO of the company since 2014. | Director/Board Member | - |
Precedenti posizioni note di Alexander Roderick MacKenzie
Società | Posizione | Fine |
---|---|---|
PFIZER, INC. | Corporate Officer/Principal | 21/03/2022 |
Duke University
Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | Corporate Officer/Principal | - |
Formazione di Alexander Roderick MacKenzie
Imperial College London | Doctorate Degree |
University of Glasgow | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
PFIZER, INC. | Health Technology |
Aziende private | 3 |
---|---|
The National Health Council
The National Health Council Miscellaneous Commercial ServicesCommercial Services The National Health Council provides united voice for people with chronic diseases and disabilities and their family caregivers. The company was founded in 1920 and is headquartered in Washington, DC. | Commercial Services |
ViiV Healthcare Ltd.
ViiV Healthcare Ltd. Pharmaceuticals: MajorHealth Technology ViiV Healthcare Ltd. manufactures and distributes pharmaceutical products. Its medicine include Triumeq, Tivicay, Selzentry, Celesentri, Epzicom, Kivexa, Ziagen, Trizivir, Combivir, Retrovir AZT, Lexiva, Telzir, Viracept and Rescriptor. The company was founded in 2009 and is headquartered in Brentford, the United Kingdom. | Health Technology |
Transcelerate Biopharma, Inc.
Transcelerate Biopharma, Inc. BiotechnologyHealth Technology Transcelerate Biopharma, Inc. is a non-profit consortium that collaborates with pharmaceutical and biotechnology companies to improve the delivery of new medicines. The non-profit company is based in King of Prussia, PA. The organization's mission is to identify, prioritize, design, and facilitate implementation of solutions to drive the efficient, effective, and high-quality delivery of new medicines. Transcelerate has 20 member companies and 30+ initiatives focused on improving the patient and site experience, enhancing sponsor efficiencies and drug safety, and harmonizing processes and sharing information. The company was founded by Garry Arthur Neil, and Janice Chang has been the CEO of the company since 2014. | Health Technology |
- Borsa valori
- Insiders
- Alexander Roderick MacKenzie